Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2

Lili Hu1,2, Renee M van der Sluis1,2, Kennith Brian Castelino1

  • 1Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Nature Communications
|November 27, 2025
PubMed

Insights

Rare variants in RB1CC1, encoding FIP200 protein, are linked to critical COVID-19. FIP200 deficiency impairs a novel pathway that degrades SARS-CoV-2, independent of type I interferon.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • COVID-19 severity varies, with type I interferon deficiency implicated in severe cases.
  • RB1CC1 gene variants, encoding FIP200, were investigated in patients with critical COVID-19.

Purpose of the Study:

  • To investigate the role of FIP200 in SARS-CoV-2 infection and COVID-19 pathogenesis.
  • To identify the antiviral mechanisms involving FIP200.

Main Methods:

  • Analysis of patients with critical COVID-19 and RB1CC1 variants.
  • Genetic manipulation of FIP200 in airway epithelial cells and cell lines.
  • Assessment of SARS-CoV-2 replication and autophagic flux.
  • Investigation of FIP200's interaction with NDP52 and its role in viral degradation pathways.

Main Results:

  • Two unrelated male patients with critical COVID-19 had rare deleterious RB1CC1 variants.
  • FIP200-deficient cells and cells with patient variants showed increased SARS-CoV-2 replication and impaired autophagic flux.
  • FIP200 mediates SARS-CoV-2 degradation via a novel, non-canonical pathway involving NDP52 and lysosomal degradation, independent of canonical autophagy and type I IFN.

Conclusions:

  • A cell-autonomous antiviral pathway dependent on FIP200 and NDP52 restricts SARS-CoV-2.
  • This pathway, independent of canonical autophagy and type I IFN, targets virions for degradation in acidified vesicles.
  • Impairment of this FIP200-dependent pathway may contribute to critical COVID-19 pneumonia.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K